Effects of lapatinib and trastuzumab on progression free survival
15 Jun 2012
Effects of lapatinib and trastuzumab on progression free survival
President's overview of ASCO 2012
Afatinib delays progression of advanced lung adenocarcinomas
Routine molecular testing of non-small cell lung cancers in community settings
Increased progression-free survival in advanced lung cancer with afatinib
Bendamustine regimen more effective for lymphoma than standard CHOP
Problems in the structure of clinical trials
Prognostic biomarkers and next generation genomic sequencing
Use of bio-banks in the EurocanPlatform
Recent developments in neoadjuvant therapy
Highlights and goals of IMPAKT 2012
PI3K and the heterogeneity of small tumour breast cancer